Parkinsons Disease Drugs Market
Market Overview:
The disease of Parkinson is a chronic disorder that gradually contributes to a progressive deterioration of motor functions triggered by the loss of brain cells producing dopamine. Because of the growing instances of Parkinsons illness with the development in aging population levels, the Parkinsons disease drugs market is anticipated to experience important development. Therefore, during the forecast period, it may lead dramatically in raising the size of the market. Pharmaceutical firms are developing new and improved therapies for Parkinsons disease PD , and in Parkinsons disease therapies and other assistive therapies there have recently been some major product launches. For example, the amantadine extended-release capsules / Gocovri of Adamas Pharmaceuticals launched in January 2018, the first drug indicated for dyskinesia developed as a result of long-term levodopa use. Moreover, most global firms have a robust drug pipeline to treat Parkinsons disease, and the forecast period may be witnessing the launch of a few blockbuster drugs, according to estimates.
Report Portfolio:
The market parkinsons disease drug has been segmented by action mechanism and geography. The market studied is segmented by the mechanism of action into dopamine agonists, anticholinergic agents, MAO-B inhibitors, amantadine, carbidopa-levodopa, COMT inhibitors and other mechanisms of action. The market is divided into North America, Europe, Asia-Pacific, South America, and Middle East and Africa by geography.
Get a Free Sample Copy of this Report @ https://www.planetmarketreports.com/report-sample/parkinsons-disease-drugs-market
Key Market Trends:
COMT Catechol-O-Methyltransferase Inhibitors are expected to register robust growth:
Carbidopa-levodopa therapy is the most effective drug to relieve PD motor symptoms. However, this medication has been observed not to be as effective as intended. Therefore, co-therapeutic agents such as inhibitors of COMT catechol-O-methyltransferase together with carbidopa-levodopa treatment are essential. Comtan entacapone and Tasmar tolcapone are the two most prevalent COMT inhibitors used in the therapy of Parkinsons disease. Both of these drugs are accessible in tablet form. Furthermore, in combination with carbidopa-levodopa treatment, these medicines are regularly prescribed.
United States Represents the Largest Market for Parkinsons Disease Therapeutics:
Approximately 1.2 million people in the United States are predicted to have Parkinsons disease by 2030 according to the National Institute of Health. It is the United States second most prevalent neurodegenerative disease. Moreover, there are thousands of undetected patients. As the rates of the aging population continue to increase, the amount of individuals suffering from Parkinsons illness PD will continue to increase, and this is anticipated to double by 2040. Combined with the availability of reimbursements and elevated awareness, the sheer amount of Parkinsons disease patients is boosting market growth. In addition, the high cost of Parkinsons disease therapy in the U.S. also leads to significant revenue size of the market. The average price of Parkinsons medication is about USD 2,500 per year and up to USD 100,000 per patient can cost Parkinsons related surgery.
Get More Information about this Report and TOC @ https://www.planetmarketreports.com/reports/parkinsons-disease-drugs-market
Competitive Landscape Report:
The drugs market for the Parkinsons disease becomes extremely competitive. The latest product launches and the large amount of therapies in worldwide pharmaceutical companies product pipelines contribute to the markets vibrant nature. During the forecast period, several new product launches are anticipated, which can lead to important modifications in the market shares of presently active pharmaceutical companies.
About Us: –
Planet Market Reports gives statistical surveying reports to businesses, people and associations with a goal of helping them in their decision-making process. We have a huge database of market research reports & company profiles across the globe. We offer premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.
Planet Market Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, & industry experts which provide you deeper penetration of market research industry ensuring you will receive the most reliable and up to date research data available.
Name: Jennifer Daniel
Email-Id: sales@planetmarketreports.com
US: +1-716-2260907
UK: +447441952057
Organization: Planet Market Reports
